Kore Private Wealth’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-838
Closed -$312K 352
2021
Q3
$312K Sell
838
-24
-3% -$9.12K 0.03% 325
2021
Q2
$329K Buy
862
+198
+30% +$75.7K 0.04% 297
2021
Q1
$238K Buy
664
+9
+1% +$2.89K 0.03% 314
2020
Q4
$210K Buy
+655
New +$201K 0.03% 303
2020
Q3
Sell
-473
Closed -$124K 502
2020
Q2
$124K Sell
473
-78
-14% -$20.8K 0.03% 305
2020
Q1
$125K Sell
551
-40
-7% -$10.9K 0.03% 277
2019
Q4
$178K Buy
+591
New +$163K 0.03% 264
2019
Q2
Sell
-232
Closed -$67K 400
2019
Q1
$67K Buy
232
+10
+5% +$2.89K 0.02% 331
2018
Q4
$58K Buy
+222
New +$61K 0.02% 343

Other funds holding ELV

Kore Private Wealth's ELV Position: Q4 2021 in Review

Kore Private Wealth sold out of Elevance Health (ELV) in Q4 2021, closing a stake of 838 shares — an estimated $312K sold.

Kore Private Wealth first reported a position in ELV in Q4 2018 and held it in 9 quarters. The position peaked at $329K in Q2 2021. 1,372 funds tracked by Wall St. Rank hold ELV as of Q4 2021.

  • Kore Private Wealth reported no remaining Elevance Health position as of Q4 2021 after selling out during the quarter.
  • Kore Private Wealth sold 838 Elevance Health shares in Q4 2021, an estimated $312K.
  • Kore Private Wealth first reported a position in Elevance Health in Q4 2018 and held it in 9 quarters.
  • Kore Private Wealth's Elevance Health position peaked at $329K in Q2 2021.
  • 1,372 funds tracked by Wall St. Rank held Elevance Health as of Q4 2021.

Based on Kore Private Wealth's 13F filing for Q4 2021, filed 11 Feb 2022.